Why are you looking at Exelan Pharmaceuticals?
Email me when a Exelan Pharmaceuticals recompete window opens.
Capability
Service linesPHARMACEUTICAL PREPARATION MANUFACTURING
Work mix: 100% prime · 0% sub · primary NAICS 325412 / PSC 6505 DRUGS AND BIOLOGICALS
Where they win
3 agenciesRecompete exposure: High · 49 in 24mo
Exelan Pharmaceuticals has an estimated $180.8M in contracts returning to market over the next 24 months.
Agency buyer map
3 buyersRecompete exposure
HighExelan Pharmaceuticals has an estimated $180.8M in contracts returning to market over the next 24 months. 45 within 6 months ($100.1M).
Soonest 12 of 49 to expire.
“SCOUT saves the hours of analysis that capture and proposal teams cannot afford to lose by delivering analyzed intelligence. Incumbent history, competitive positioning, and agency buying patterns get synthesized into…”
Enter your company name and we'll build the page.
Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →
Frequently asked questions
What federal contracts does Exelan Pharmaceuticals hold?
Exelan Pharmaceuticals (UEI FYZXNHSQTMG8) shows $184.3M across 125 award actions in SCOUT’s public USASpending-backed profile, with Department of Veterans Affairs (VA) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.
How much in federal contracts does Exelan Pharmaceuticals have?
Exelan Pharmaceuticals shows $184.3M across 125 award actions. SCOUT tracks 49 incumbent recompetes ($180.8M) returning to market in the next 24 months.
Which agencies does Exelan Pharmaceuticals work with?
Exelan Pharmaceuticals’s firm-wide obligated mix is led by Department of Veterans Affairs (VA) (60%), Department of Health and Human Services (HHS) (40%), Department of Justice (DOJ) (0%).
What is the UEI for Exelan Pharmaceuticals?
The Unique Entity ID (UEI) for Exelan Pharmaceuticals is FYZXNHSQTMG8.
Does Exelan Pharmaceuticals have contracts coming up for recompete?
Yes — SCOUT tracks 49 incumbent recompetes in the next 24 months (High exposure). Open the recompete section on this page for PIID-level timing.
Seen enough? Run one full capture cycle on Exelan Pharmaceuticals — $90 for 90 days.
This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.
$1/day · one payment · no subscription
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.